Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$16.93 - $31.33 $80,197 - $148,410
4,737 Added 558.61%
5,585 $102,000
Q4 2023

Feb 14, 2024

BUY
$25.21 - $34.66 $3,478 - $4,783
138 Added 19.44%
848 $23,000
Q3 2023

Nov 14, 2023

SELL
$26.91 - $35.49 $1,130 - $1,490
-42 Reduced 5.59%
710 $21,000
Q2 2023

Aug 14, 2023

SELL
$25.15 - $32.86 $2,238 - $2,924
-89 Reduced 10.58%
752 $24,000
Q1 2023

May 15, 2023

BUY
$17.5 - $25.9 $927 - $1,372
53 Added 6.73%
841 $21,000
Q3 2022

Nov 14, 2022

SELL
$14.66 - $18.3 $2,345 - $2,928
-160 Reduced 16.88%
788 $14,000
Q2 2022

Aug 15, 2022

BUY
$14.1 - $20.26 $1,142 - $1,641
81 Added 9.34%
948 $14,000
Q1 2022

May 16, 2022

BUY
$15.23 - $21.47 $2,817 - $3,971
185 Added 27.13%
867 $17,000
Q4 2021

Feb 14, 2022

BUY
$21.65 - $27.0 $14,765 - $18,414
682 New
682 $12,000

Others Institutions Holding STVN

About Stevanato Group S.p.A.


  • Ticker STVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 264,700,000
  • Market Cap $5.44B
  • Description
  • Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machine...
More about STVN
Track This Portfolio

Track Amundi Portfolio

Follow Amundi and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.